Gyre Therapeutics Inc (GYRE)
7.80 x 1 9.00 x 10
Post-market by (Cboe BZX)
7.72 -1.39 (-15.26%) 03/31/25 [NASDAQ]
7.80 x 1 9.00 x 10
Post-market 7.41 -0.31 (-4.02%) 16:23 ET
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,369 | 31,263 | 19,805 | 29,732 | 62,890 |
| Marketable Securities | 61,496 | 88,914 | 17,971 | 6,800 | 3,402 |
| Receivables | 15,000 | N/A | N/A | 31 | 492 |
| Other current assets | 0 | 0 | 0 | 0 | 133 |
| TOTAL | $96,066 | $123,991 | $39,109 | $37,521 | $68,698 |
| Non-Current Assets | |||||
| PPE Net | 304 | 386 | 276 | 444 | 698 |
| Other Non-Current Assets | 2,184 | 543 | 128 | 125 | 125 |
| TOTAL | $2,488 | $929 | $404 | $569 | $823 |
| Total Assets | $98,554 | $124,920 | $39,513 | $38,090 | $69,521 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,085 | 19,403 | 33,743 |
| Accounts payable and accrued liabilities | 4,279 | 1,248 | 747 | 837 | 939 |
| Accrued Expenses | 2,106 | 1,495 | 1,366 | 596 | 926 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,156 |
| TOTAL | $28,899 | $4,801 | $8,739 | $21,965 | $37,756 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,000 | 15 | 219 | 324 | 457 |
| aiOther Non-Current Liabilities | 1,319 | 0 | 0 | 0 | 0 |
| TOTAL | $1,319 | $174 | $N/A | $54 | $340 |
| Total Liabilities | $30,218 | $4,975 | $8,739 | $22,019 | $38,096 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 806 | 798 | 793 | 67 | 51 |
| Common Shares | 12 | 12 | 6 | 1 | 1 |
| Retained earnings | -258,520 | -203,342 | -173,494 | -147,982 | -131,037 |
| Other shareholders' equity | 34 | -4 | 0 | -1 | 1 |
| TOTAL | $68,336 | $119,945 | $30,774 | $16,071 | $31,425 |
| Total Liabilities And Equity | $98,554 | $124,920 | $39,513 | $38,090 | $69,521 |